However, the high RARγ-expression group had a significantly worse prognosis than the low-expression group in pancreatic cancer (median OS 15.7 vs. 24.6 months, p = 0.0011) (Fig. 1c). The gene discussed is RARG; the disease is familial pancreatic carcinoma.